HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of Heparin Quick Penetrating Solution and Diclofenac Quick Penetrating Solution for the Prevention of Superficial Thrombophlebitis Caused by Peripheral Venous Cannulation: A Randomized Double-Blind Study.

AbstractBACKGROUND AND AIMS:
The association of superficial thrombophlebitis (ST) with deep-venous thrombosis varies between 6% and 44%. Thus, prevention of ST is important. The aim of this study was to compare the efficacy of topical quick penetrating solution (QPS) of heparin 1000 IU/mL versus diclofenac QPS for prevention of postinfusion ST.
SETTINGS AND DESIGN:
This is a randomized, controlled, double-blind study.
MATERIALS AND METHODS:
The study was done after ethical clearance and Clinical Trial Registry- India registration to compare 100 patients for the prevention of ST with application of heparin QPS and diclofenac QPS at regular intervals. Patients were randomized into two groups (Group H [control group] - heparin QPS group and Group D - diclofenac QPS group) and the assigned treatment was applied four times daily. The appearance of thrombophlebitis was graded on the basis of infusion nursing society scale. The site of venous cannulation was inspected every 6 h for any changes for the next 5 days.
STATISTICAL ANALYSIS:
The parametric data were analyzed using Student's t-test and nonparametric data were analyzed by Kruskal-Wallis test.
RESULTS:
Of 98, only 10 patients developed thrombophlebitis and all belonged to Group D (23%). No patient belonging to Group H developed thrombophlebitis (0%). This difference was statistically significant (P = 0.034).
CONCLUSION:
The QPS formulation of heparine and diclofenac was effective in preventing thrombophlebitis. Heparine QPS is more effective than diclofenac QPS for the same.
Authors Akhileshwar, Swati Singh
JournalAnesthesia, essays and researches (Anesth Essays Res) 2019 Jan-Mar Vol. 13 Issue 1 Pg. 155-157 ISSN: 0259-1162 [Print] India
PMID31031497 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: